Strategy for the retreatment of failed Helicobacter pylori eradication therapy: A case series

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 4, 1998, Pages 370-374

  Battaglia, G ^a,d   Di Mario, F ^b   Vigneri, S ^c   Vianello, F ^d   Benvenuti, M E ^a   Donisi, P M ^b   Stracca Pansa, V ^c   Pasquino, M ^d  

^a Gastroenterology Unit   (Italy)

^b Gastroenterology Unit   (Italy)

^c Pathology Unit of venezia   (Italy)

^d Servizio di Gastroenterologia ed Endoscopia Digestiva   (Italy)

Author keywords

Clarithromycin; Helicobacter pylori eradication; Metronidazole; Omeprazole

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH CITRATE; CLARITHROMYCIN; IMIDAZOLE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL PROTOCOL; DIARRHEA; EPIGASTRIC PAIN; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRURITUS; RETREATMENT; TREATMENT FAILURE; VERTIGO;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 0031684223     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Out 1997;41:8-13.
2. Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallak A, Tiomny E, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment PharmacolTher 1996;10:1015-9.
3. Van der Hülst RW, Weel JF, van der Ende A, ten Kate FJ, Danken J, Tytgat GN. Therapeutic options after failed Helicobacter pylori eradication therapy. Am J Gastroenterol 1996;91:2333-7.
4. Van der Hülst RW, Weel JF, Verheul SB, Keller JJ, ten Kate FJ, van der Ende A, et al. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with ampxycillin and the effect of early retreatment. Aliment Pharmacol Ther 1996:10:165-71.
5. Zala G, Schwery S, Giezendanner S, Flury R, Wust J, Meyenberger C et al. Wirksamkeit der Tripeltherapie zur eradikation von H. pylori bei Therapieversagern mit Omeprazol/Amoxicylin. Schweiz Med Wochenschr 1996;126:153-8.
6. Imperiale TF, Speroff T, Cebul RD, McCullogh AJ. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med 1995:123:665-72.
7. Rinaldi V, Zullo A, Pugliano F, Valente C, Diana F, Attili AF. The management of failed dual or triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1997:11:929-33.
8. Alarcon T, Domingo D, Sanchez I, Sanz I, Sanz JC, Lopez-Brea M. Susceptibility to metronidazole and clarithromycin amongst Helicobacter pylori clinical isolates from the same patient. Gut 1996;39(Suppl 2):A12.
9. Xia HX, Buckley M, Keane CT, O'Morain C. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother 1996;37:473-81.
10. Lerang F, Mourn B, Haug JB, Tolas P, Breder O, Aubert E, et al. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am J Gastroenterol 1997;92:248-53.
11. Moayyedi P, Tompkins DS, Ragunathan PL, Axon ATR. Relevance of metronidazole resistance in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate Helicobacter pylori. Gut 1996;39(Suppl 2):A6.
12. Peitz U, Nusch A, Tillenburg B, Stolte M, Borsch G, Labenz J. High cure rate of H. pylori (HP) infection by one-week therapy with omeprazole (Ome), metronidazole (Met) and clarithromycin (Cla) despite a negative impact by Met resistance. Gut 1996;39(Suppl 2):A34.